Why focus on Lp(a)?

10' education - Sep. 13, 2021 - Prof. Naveed Sattar, MD, PhD - Glasgow, UK - Online CME

Video navigation menu

Overview on lipoproteins 0:21
What is Lp(a)? 2:04
Lp(a) and CVD 4:55
Lp(a) reduction 6:50

Do you measure Lp(a) in all your patients?

Yes, at least once in all adult patients
No, only in those with high LDL-c levels
No, because there is no therapy

Educational information

This lecture by prof. Naveed Sattar was part of an accredited symposium "Lp(a): from CV risk marker to therapeutic target" held during the virtual ESC Congress 2021.

Faculty

Naveed Sattar, MD, PhD is Professor of Metabolic Medicine, University of Glasgow. He is an academic (active clinically) experienced in biomarker studies/trials investigating the causes, prevention and management of diabetes, obesity and heart disease.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by unrestricted educational grants received from Sanofi and Novartis.

Click here for the meeting report View slides of this presentation

Online-CME

This is available as accredited online CME on coursepath for members. Click the button below to enroll:

Enroll

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.